TCW — Deck
Trican is a Calgary-based pure-play pressure pumper that rents frac crews, cementing trucks, and coiled-tubing units to oil and gas producers in Western Canada, charging per-job fees collected on 60–80 day terms.
May 12 resolves the whole debate — a single earnings print decides cycle-turn or cycle-peak.
- Management just named it. The Q4 2025 MD&A flagged pricing pressure continuing into Q1 2026 and customers "deferring or cancelling" capital programs — the first time that language has appeared since FY2020. WCSB rig count fell from 231 in Q1 2025 to 196 in Q4 2025.
- The margin hinge is 18%. At a 55% direct-cost base, a 5% pricing cut strips roughly $40M of EBITDA off the $175M FY25 run-rate — collapsing margin from 21.9% toward 16%. Anything below 18% on May 12 confirms pricing has cracked; at or above 21% reopens the compounding story.
- The tape is already voting. Stock topped at $5.80 in late March, sits 9% below the 50-day and only 3% above the 200-day ($4.51). A weekly close under $4.51 triggers the measured path to $4.02, then $3.21.
Cleanest balance sheet in WCSB pumping at a bottom-quartile multiple.
Margins stabilized at mid-teens for four consecutive years — unusual for a sub-industry whose direct peers (Calfrac 5.5% ROIC, STEP 0%, Precision 0.2%) earn sub-6% through-cycle. Trican's 16.3% ROIC reflects pricing discipline in a basin that consolidated after smaller operators exited. The 5.6× multiple sits above the post-2020 average of 4.8× but well below the 6.5–7.0× fair-cycle anchor; closing that gap needs the FY25 margin band to hold through the Q1 2026 print.
A buyback, not a business, is what has compounded value here.
- 52% of the 2017 float retired. Trican has bought back and cancelled 179.2M shares since 2017 at a weighted-average $2.20 — well below today's $4.67 — for roughly $394M. The cumulative NCIB is ex post accretive by about 2.2× invested capital.
- $70M returned in 2025 alone. $30M dividends plus $40M in buybacks, roughly 9% of the market cap in one year, against $109M of free cash flow. Dividend raised 10% to $0.04/quarter.
- Per-share, not empire. 86% at-risk CEO pay, zero option grants since 2022, STIP capped with overflow deferred to LTIP. Board chair is an industry operator; a 9% shareholder-director (Coolen, ex-Iron Horse) sits on the capital-return side of every decision.
The first acquisition in seven years landed on the wrong side of the oil curve.
Bought: $57M cash plus 33.76M shares — roughly 20% of the pre-deal float — closed August 27, 2025. Pitched at under 3× EBITDA, targeting ~$58M of run-rate EBITDA and billed as immediately accretive with double-digit lifts to EBITDA, FCF, and earnings. Trican-Canada's first M&A since the 2017 Canyon deal.
Missed: Oil cracked four weeks after close. Iron Horse H2 2025 contribution came in at $55M revenue and $1.7M profit; Q4 ran below plan. On the February 20 call, CEO Fedora conceded the ~$58M EBITDA bar will likely be missed in 2026 — a public downgrade of the deal economics versus how it was sold in July.
Price: Net debt swung from −$18M (2024) to +$58M (2025), first non-zero debt since 2021. Share count ticked from 188.9M to 210.8M, reversing 2024's buyback progress. Of FY25's $84M YoY revenue growth, roughly $55M came from Iron Horse — organic growth was low single-digits on a price base that has since cracked.
The Q4 call and the tape send different messages than the glossy outlook deck.
- CFO bought, CEO is thin. CFO Matson bought roughly $95k of stock around the Iron Horse close — a rare positive insider signal. But CEO Fedora owns just 0.48% (~$4.7M), only 1.5× annual comp after five years in the chair — light for a tenured CEO through an up-cycle.
- Analyst target: $5.51. The post-print sell-side target was raised to $5.51 — roughly 18% above the April 17 close. The DCF mid-point ($5.76) and base-case 6.5× multiple ($5.11) bracket it.
- MACD is at an 18-month low. Momentum histogram printed its deepest negative bar of the entire window on April 16; RSI fell from 73 to 33 in eleven weeks. Volume is running above the 50-day average in five of the last eight weeks — distribution, not profit-taking.
Lean cautious — wait for May 12 before the buyback story gets a second chapter.
- For. A 52%-of-float buyback at $2.20 proves management uses weakness, not conviction, to compound per-share value — and they raised the dividend twice in 2025 while the stock was still below $5.
- For. At 0.3× net debt to EBITDA and 35× interest coverage, Trican is the only WCSB pumper that can absorb a 2016-style trough without recapitalizing through equity — which is exactly how the competitive set thinned out.
- Against. Iron Horse already missed its own Q4 numbers, debt went from −$18M to +$58M, and the 20% dilution reversed two years of NCIB progress right as pricing cracked. Cycle-peak ROIC is not through-cycle ROIC.
- Against. The 200-day ($4.51) is 3% below the tape, MACD at an 18-month low, and the base-case Graham ($4.29) and median-P/S ($4.10) anchors both sit below today's price. The asymmetry is no longer obviously positive.
Watchlist to re-rate: Q1 2026 EBITDAS margin on May 12 (18% is the line); whether the NCIB restarts at these $4–5 prices; WCSB rig count trajectory from 196 back toward 220.